(43 days)
No
The summary does not mention AI, ML, or any related terms, and the device description focuses on standard fetal monitoring functionalities.
No.
The device is a monitor used to assess fetal well-being, not to treat a medical condition.
Yes
Explanation: The device monitors "fetal well being during the antepartum period," and gathers various physiological parameters such as FHR, TOCO, and optional DECG and IUP, which are then displayed and recorded. These actions are indicative of gathering information to determine a medical condition or health status, which falls under the definition of a diagnostic device.
No
The device description explicitly mentions hardware components such as a 5.7" LCD and a built-in thermal recorder, indicating it is not a software-only device.
Based on the provided information, the CADENCE II fetal monitor is not an In Vitro Diagnostic (IVD) device.
Here's why:
- IVD Definition: In Vitro Diagnostics are medical devices used to examine specimens taken from the human body (like blood, urine, or tissue) to provide information about a person's health.
- CADENCE II Function: The CADENCE II fetal monitor directly monitors physiological signals from the fetus (FHR, TOCO, etc.) using external sensors or internal probes. It does not analyze specimens taken from the body.
- Intended Use: The intended use describes monitoring fetal well-being during the antepartum period, which is a direct physiological measurement, not an analysis of a biological sample.
Therefore, the CADENCE II fetal monitor falls under the category of a physiological monitoring device, not an IVD.
N/A
Intended Use / Indications for Use
The CADENCE II fetal monitor is used to monitor fetal well being during the antepartum period what is commonly called the non stress test. It is to be used by trained medical personnel in hospitals, clinics, physicians offices and in the patients home by prescription or doctors orders.
Product codes
HGM
Device Description
The CADENCE II Fetal Monitor can provide different configurations according to different user requirements, FHR1 (US1), FHR2 (US2), TOCO, FM (remote marker), AFM (automatic fetal movement mark), fetal stimulator (optional), DECG (direct fetal ECG, optional), and IUP (Intra-uterine Pressure, optional). The user can select the monitors according to requirements.
CADENCE II adopts 5.7" LCD, and the collected data, trends, and monitoring parameters are displayed at the same screen. A built-in thermal recorder is used to record the monitoring information.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
trained medical personnel in hospitals, clinics, physicians offices and in the patients home by prescription or doctors orders.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc)
Not Found
§ 884.2740 Perinatal monitoring system and accessories.
(a)
Identification. A perinatal monitoring system is a device used to show graphically the relationship between maternal labor and the fetal heart rate by means of combining and coordinating uterine contraction and fetal heart monitors with appropriate displays of the well-being of the fetus during pregnancy, labor, and delivery. This generic type of device may include any of the devices subject to §§ 884.2600, 884.2640, 884.2660, 884.2675, 884.2700, and 884.2720. This generic type of device may include the following accessories: Central monitoring system and remote repeaters, signal analysis and display equipment, patient and equipment supports, and component parts.(b)
Classification. Class II (performance standards).
0
Attachment 6
B.
510(K) SUMMARY
DEC 2 8 2007
CADENCE II
Submitter's Information A.
| Name: | Edan Instruments, Inc |
|---|---|
| Address: | 3/F - B, Nanshan Medical |
| Equipments Park, Nanhai Rd 1019#, | |
| shekou, Nanshan Shenzhen, | |
| 518067 P. R. China | |
| Phone: | 86-755-26892220 |
| Fax: | 86-755-26882223 |
| Contact Person: | Jiang Yucai |
| Official Correspondent: | William Stern |
| Date Summary Prepared: | Oct 17, 2007 |
Device Information
| Trade/Device Name: | CADENCE II |
|---|---|
| Regulation Number: | 884.2740 |
Classification Name: System, Monitoring, Perinatal Regulation Class: Class II Product Code: HGM Classification Panel: Obstetrics/Gynecology
Description of Device
The CADENCE II Fetal Monitor can provide different configurations according to different user requirements, FHR1 (US1), FHR2 (US2), TOCO, FM (remote marker), AFM (automatic fetal movement mark), fetal stimulator (optional), DECG (direct fetal ECG, optional), and IUP
1
(Intra-uterine Pressure, optional). The user can select the monitors according to requirements.
CADENCE II adopts 5.7" LCD, and the collected data, trends, and monitoring parameters are displayed at the same screen. A built-in thermal recorder is used to record the monitoring information.
C. Predicate Device Information
Cadence [K040903] [09/02/2004]
D. Indications for Use/Intended Use
The CADENCE II fetal monitor is used to monitor fetal well being during the antepartum period what is commonly called the non stress test. It is to be used by trained medical personnel in hospitals, clinics, physicians offices and in the patients home by prescription or doctors orders.
E. Substantial Equivalence
1 ls the product a device? YES-The CADENCE II is a device.
- Does the new device have the same intended use? YES-The intended use for the CADENCE II is equivalent to that for the Cadence and is as follows:
Intended Use: Cadence
The Cadence fetal monitor is used to monitor fetal well being during the antepartum period what is commonly called the non stress test. It is to be used by trained medical personnel in hospitals, clinics, physicians offices and in the patients home by prescription or doctors orders.
- Does the device have technological characteristics the raise new types of safety or effectiveness questions?
NO- The technological characteristics of the CADENCE II raise no new types of safety or effectiveness questions.
- Does descriptive or performance information demonstrate equivalence?
YES- Edan Instruments, Inc. believes that the information provided
2
in this submission clearly describes the CADENCE II and demonstrates that it is substantially equivalent to the predicate device Cadence
H. Safety Summary
Edan Instruments, Inc. made several modifications to the Cadence cleared under K040903. All design control activities including safety risk analysis and the verification and validation activities conducted as related to the risks proved that the modified CADENCE II is substantially equivalent in intended use, design, principle of operations, performance, and contains the same fundamental scientific technology as the Cadence.
3
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/3/Picture/1 description: The image shows the seal of the Department of Health & Human Services (HHS) of the United States. The seal features the department's name encircling a stylized emblem. The emblem consists of three abstract shapes resembling human figures or birds in flight, arranged in a stacked formation.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
DEC 2 8 2007
Edan Instruments, Inc. % Mr. William Stern Multigon Industries, Inc. 1 Odell Plaza YONKERS NY 10701
Re: K073221
Trade/Device Name: CADENCE II Regulation Number: 21 CFR 884.2740 Regulation Name: Perinatal monitoring system and accessories Regulatory Class: II Product Code: HGM Dated: November 7, 2007 Received: December 5, 2007
Dear Mr. Stern:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
4
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the est on ic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Crant on the of the following numbers, based on the regulation number at the top of this letter.
| 21 CFR 876.xxxx | (Gastroenterology/Renal/Urology) | 240-276-0115 |
|---|---|---|
| 21 CFR 884.xxxx | (Obstetrics/Gynecology) | 240-276-0115 |
| 21 CFR 892.xxxx | (Radiology) | 240-276-0120 |
| Other | 240-276-0100 |
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket surveillance, recuract CDRH s Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at 24/0276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at 240-276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.btml
Sincerely yours.
Nancy C. Brogdon
Nancy C. Brogdon Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
Attachment 2
Indications for Use Statement
510 (k)
Number
(if known)
Kot 32a/
CADENCE II Device Name
The CADENCE II fetal monitor is used to monitor fetal well Indications for Use being during the antepartum period what is commonly called the non stress test. It is to be used by trained medical personnel in hospitals, clinics, physicians offices and in the patients home by prescription or doctors orders.
PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use YES (Per 21 CFR 801 Subpart D) OR
Over-The-Counter Use _ NO
tony m whay
(Division S Division of Reproductive, Abdominal and Radiological Devices 510(k) Number